Rosa Lerose

Rionero In Vulture, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Impact of immunotherapy in the treatment of early-stage non-small lung cancer, melanoma, and colorectal cancer.

Impact of immunotherapy in the treatment of early-stage non-small lung cancer, melanoma, and colorectal cancer.

Journal: Immunotherapy
Published: August 24, 2026

Cyclophosphamide and Etoposide: A mathematical evaluation of the decay of two highly reactive molecules.

Cyclophosphamide and Etoposide: A mathematical evaluation of the decay of two highly reactive molecules.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: June 11, 2025

Microwave-assisted synthesis of tubulin assembly inhibitors as anticancer agents by aryl ring reversal and conjunctive approach.

Microwave-assisted synthesis of tubulin assembly inhibitors as anticancer agents by aryl ring reversal and conjunctive approach.

Journal: RSC medicinal chemistry
Published: May 09, 2025

The Oncoprotein Mucin 1 in Pancreatic Cancer Onset and Progression: Potential Clinical Implications.

The Oncoprotein Mucin 1 in Pancreatic Cancer Onset and Progression: Potential Clinical Implications.

Journal: Biomolecules
Published: December 11, 2024

Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort ("PEMBROREAL" Study).

Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort ("PEMBROREAL" Study).

Journal: Cancers
Published: April 15, 2024

A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL).

A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL).

Journal: Frontiers in oncology
Published: December 07, 2023

Biological evaluation of [4-(4-aminophenyl)-1-(4-fluorophenyl)-1H-pyrrol-3-yl](3,4,5-trimethoxyphenyl)methanone as potential antineoplastic agent in 2D and 3D breast cancer models.

Biological evaluation of [4-(4-aminophenyl)-1-(4-fluorophenyl)-1H-pyrrol-3-yl](3,4,5-trimethoxyphenyl)methanone as potential antineoplastic agent in 2D and 3D breast cancer models.

Journal: Archiv der Pharmazie
Published: July 01, 2023

Current Treatment Approaches for Thymic Epithelial Tumors.

Current Treatment Approaches for Thymic Epithelial Tumors.

Journal: Life (Basel, Switzerland)
Published: February 27, 2023

Potential Role of Tumor-Derived Exosomes in Non-Small-Cell Lung Cancer in the Era of Immunotherapy.

Potential Role of Tumor-Derived Exosomes in Non-Small-Cell Lung Cancer in the Era of Immunotherapy.

Journal: Life (Basel, Switzerland)
Published: October 29, 2022

Decisions and dilemmas in non-metastatic castration-resistant prostate cancer management.

Decisions and dilemmas in non-metastatic castration-resistant prostate cancer management.

Journal: Medical oncology (Northwood, London, England)
Published: March 26, 2022

Management of oligoprogression in non-small cell lung cancer patients.

Management of oligoprogression in non-small cell lung cancer patients.

Journal: Medical oncology (Northwood, London, England)
Published: December 12, 2021

Focus on lung cancer screening.

Focus on lung cancer screening.

Journal: Journal of thoracic disease
Published: August 18, 2020
Showing 1-12 of 32

Last Updated: 09/26/2026